How can health technology assessment be improved to optimise access to medicines? Results from a Delphi study in Europe

ConclusionsOur results reiterate that increased transparency during HTA and the decision-making processes is essential; the use of and reliance on new evidence generation such as real-world evidence can optimise the availability of medicines; and better collaborations between regulatory institutions within and between countries are paramount for better access to medicines.
Source: The European Journal of Health Economics - Category: Health Management Source Type: research